thyroid eye disease

SOUTH SAN FRANCISCO, Calif., June 29, 2026 Genentech, a member of the Roche Group, announced that the U.S. Food...

WALTHAM, Mass., June 26, 2026 Viridian Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved Lumvoa™...

TARRYTOWN, N.Y., June 4, 2026 Regeneron Pharmaceuticals has unveiled a broad slate of new clinical and preclinical research across...

SAN FRANCISCO and SUZHOU, China, May 18, 2026 Innovent Biologics presented new clinical and preclinical data from its next-generation...

WALTHAM, Mass., United States – May 5, 2026 Viridian Therapeutics Inc. has announced positive topline results from its Phase...

Thousand Oaks, California, USA, April 6, 2026 Phase 3 Success Expands TEPEZZA Treatment Options In a major advancement for...